Skip to main content
OpenTrials
Completed

NCT Number: NCT00795223

Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA

Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine for single femoral nerve block

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Siriraj Hospital

Bangkok, Bangkoknoi, 10700, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Single elective total knee replacement in ASA 1-3 without significant cardiovascular limitation

Exclusion criteria

  • patient at risk in usage COX-2 for post operative pain control

Treatment and study plan

morphine and bupivacaine

Drug

0.3 mg morphine for spinal together with 0.5% bupivacaine for femoral nerve block

Other names: marcaine

spinal morphine and marcaine

Drug

0.3 mg spinal morphine together with 0.25% bupivacaine for femoral nerve block

Other names: marcaine

Primary outcomes

  1. Global assessment in post operative pain control

    Time frame: Begining of first enrollment in december 2008

Secondary outcomes

  1. Global assessment of post operative pain in 48 HOURS AND SIDE EFFECTS

    Time frame: first enrollment in December 2008

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Collaborators

  • Siriraj Hospital

Registry information

Official study title

Comparative Effect of 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for Femoral Nerve Block After Total Knee Replacement

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Nov 21, 2008
Registry last updated
Sep 29, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.